Midi Health describes a virtual menopause-care service built around clinician visits, individualized care plans and insurance participation. Its HRT page discusses FDA-approved bioidentical hormones, while a separate testosterone program describes compounded treatment.
Those are different medication categories with different evidence and availability questions. A thoughtful comparison should consider the appointment model, your actual insurance benefits and the precise treatment being proposed—not simply whether the clinic offers hormones.
Start with the appointment model
Midi says an initial virtual visit includes a review of symptoms and medical history to decide whether HRT is appropriate. Its published approach includes selecting a formulation, beginning with an appropriate dose and adjusting treatment when needed. This is attractive for readers who want a scheduled conversation rather than a predominantly questionnaire-based purchase.
The website also describes other midlife care. A broad scope may be useful when sleep, vaginal symptoms and other concerns overlap, but it does not mean every symptom has a hormonal cause. Ask whether the clinician can coordinate with your existing primary-care team and who handles concerns that need an in-person examination.
What the public prices say
The HRT page listed a $250 initial self-pay visit and $150 continued-care visits at our check. Medication and laboratory charges should be confirmed separately. With insurance, the relevant number is your plan’s copay, deductible and coinsurance, not a general statement that insurance is accepted.
Midi says it is in-network with most PPO plans, with coverage varying by plan. The page states it does not participate in Medicaid or Medi-Cal and cannot treat those patients even as self-pay. It also states that Medicare beneficiaries may be seen as self-pay, with restrictions on submitting claims for Midi-related services. This is particularly important for readers approaching or past 65: verify the live policy and your individual situation before booking.
FDA-approved HRT versus compounded testosterone
Midi’s HRT page describes FDA-approved bioidentical medicines. Its testosterone page separately describes a compounded option and states that the preparation is not FDA-approved. A clinic can use different regulatory categories within the same practice. Always identify the actual prescription, not just the brand name of the service.
There is no FDA-approved testosterone formulation specifically indicated for women in the United States. The evidence base does not justify treating testosterone as a general solution for aging, weight changes or every instance of low energy. ACOG highlights the limitations of compounded hormone evidence and the need for informed discussion. Read our testosterone guide before interpreting a low laboratory result as a treatment decision.
Why state availability needs a separate check
A service may provide general menopause care more widely than it offers a particular controlled medication. Midi’s testosterone page describes state-dependent availability. We do not treat a national clinic presence as proof that every product can be prescribed in every state. Ask about the service at your actual location, including travel and follow-up.
If treatment requires tests or monitoring, ask where they happen, how results are reviewed and what is included in the visit fee. Clarify how your clinician will evaluate side effects and whether the plan can continue if you move. These practical details matter as much as the first appointment’s convenience.
Questions for someone using estrogen
Ask whether your symptoms call for systemic estrogen, local vaginal treatment or a nonhormonal option. If you have a uterus and use systemic estrogen, ask how endometrial protection is handled. If you have had a hysterectomy, explain exactly which surgery you had; do not rely on the phrase partial hysterectomy without clarification.
Discuss any history of breast or uterine cancer, unexplained bleeding, blood clots, stroke, heart disease or liver disease. A virtual setting does not make those risks less relevant. The guide to starting HRT after 60 is a useful companion if treatment would be starting later in life.
How we would compare Midi
Midi is a reasonable service to investigate when insurance participation and scheduled midlife-care visits matter to you. Gennev offers another appointment-centered comparison, while Evernow publishes a mix of visit and membership options. Get plan-specific estimates from each before choosing on cost.
Our assessment comes from public provider information, not a patient enrollment or a clinical audit. We have not verified appointment availability, clinician response times or individual insurance claims. Use the published details to prepare a shortlist, then confirm your medication, financial responsibility and follow-up plan in writing.
FOLLOW THE EVIDENCE
Sources & further reading
Provider pages support service and price descriptions. Medical guidance supports treatment explanations. Neither is a first-hand review of patient outcomes. Checked September 20, 2026.